Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target ; volume:21 ; number:1 ; day:20 ; month:2 ; year:2023 ; pages:1-3 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (20.2.2023), 1-3, 12.2023
- Urheber
-
Ouyang, Zhengxiao
Wang, Sisi
Zeng, Ming
Li, Zhihong
Zhang, Qing
Wang, Wanchun
Liu, Tang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01046-y
- URN
-
urn:nbn:de:101:1-2023042621050402093631
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ouyang, Zhengxiao
- Wang, Sisi
- Zeng, Ming
- Li, Zhihong
- Zhang, Qing
- Wang, Wanchun
- Liu, Tang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
Cyclin-dependent kinases
Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Palbociclib as a Potential Treatment for Synovial Sarcoma Patients
Cyclin-dependent kinases and rare developmental disorders
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling